Medicine & Life Sciences

1. Adenocarcinoma 62%
2. Adenosquamous Carcinoma 21%
3. Aneuploidy 52%
4. Barrett Esophagus 76%
5. Biliary Tract Neoplasms 33%
6. Biopsy 18%
7. Breast Neoplasms 21%
8. Cell Line 14%
9. Cholangiocarcinoma 36%
10. Chromosome Aberrations 15%
11. Chromosomes 17%
12. Chromothripsis 26%
13. Circulating Tumor DNA 17%
14. Cisplatin 27%
15. Clonal Evolution 29%
16. Clone Cells 21%
17. Comparative Genomic Hybridization 66%
18. Cytogenetics 17%
19. Diploidy 21%
20. DNA 30%
21. Drug Therapy 14%
22. Epithelium 18%
23. Fluorescence In Situ Hybridization 16%
24. Formaldehyde 16%
25. gemcitabine 34%
26. Genes 28%
27. Genome 56%
28. Genomic Instability 24%
29. Heterografts 16%
30. Immunohistochemistry 16%
31. Loss of Heterozygosity 74%
32. Methylation 14%
33. Multiple Myeloma 15%
34. Mutation 39%
35. Neoplasms 100%
36. NUC-1031 19%
37. Oligonucleotide Array Sequence Analysis 41%
38. Pancreas 17%
39. Pancreatic Neoplasms 56%
40. Phenotype 15%
41. Ploidies 21%
42. Population 30%
43. Prostatic Neoplasms 22%
44. Receptor, Fibroblast Growth Factor, Type 2 23%
45. Small Cell Carcinoma 18%
46. Survival 17%
47. Tetraploidy 21%
48. Therapeutics 21%
49. Triple Negative Breast Neoplasms 49%
50. Waldenstrom Macroglobulinemia 21%